# Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis

> **NCT07366255** · NA · COMPLETED · sponsor: **Shenzhen People's Hospital** · enrollment: 46 (actual)

## Conditions studied

- Skin Barrier to Water Loss
- PASI /SCORAD Index

## Interventions

- **OTHER:** Placebo topical intervention
- **OTHER:** 0.5% Tripalmitoleoylglycerol topical intervention

## Key facts

- **NCT ID:** NCT07366255
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-10
- **Primary completion:** 2026-03-05
- **Final completion:** 2026-03-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07366255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07366255, "Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07366255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*